165 related articles for article (PubMed ID: 10025766)
21. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation.
Chen CC; Chang KC; Medeiros LJ; Lee JY
J Cutan Pathol; 2016 Dec; 43(12):1102-1111. PubMed ID: 27531667
[TBL] [Abstract][Full Text] [Related]
22. Severe mosquito bite hypersensitivity, natural killer cell leukaemia, latent or chronic active Epstein-Barr virus infection and hydroa vacciniforme-like eruption.
Tokura Y; Ishihara S; Ohshima K; Hidano A; Koide M; Seo N; Takigawa M
Br J Dermatol; 1998 May; 138(5):905-6. PubMed ID: 9666846
[No Abstract] [Full Text] [Related]
23. A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts.
Yamamoto T; Tsuji K; Suzuki D; Morizane S; Iwatsuki K
J Microbiol Methods; 2007 Feb; 68(2):403-7. PubMed ID: 17141343
[TBL] [Abstract][Full Text] [Related]
24. Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): a distinctive type of cutaneous T-cell lymphoma.
Magaña M; Sangüeza P; Gil-Beristain J; Sánchez-Sosa S; Salgado A; Ramón G; Sangüeza OP
J Am Acad Dermatol; 1998 Apr; 38(4):574-9. PubMed ID: 9580256
[TBL] [Abstract][Full Text] [Related]
25. Peripheral T-cell lymphoma involving subcutaneous tissue.
Cho KH; Oh JK; Kim CW; Heo DS; Kim ST
Br J Dermatol; 1995 Feb; 132(2):290-5. PubMed ID: 7888371
[TBL] [Abstract][Full Text] [Related]
26. Hydroa vacciniforme-like lymphoproliferative disorder: A study of clinicopathology and whole-exome sequencing in Chinese patients.
Xie Y; Wang T; Wang L
J Dermatol Sci; 2020 Aug; 99(2):128-134. PubMed ID: 32682634
[TBL] [Abstract][Full Text] [Related]
27. The association of latent Epstein-Barr virus infection with hydroa vacciniforme.
Iwatsuki K; Xu Z; Takata M; Iguchi M; Ohtsuka M; Akiba H; Mitsuhashi Y; Takenoshita H; Sugiuchi R; Tagami H; Kaneko F
Br J Dermatol; 1999 Apr; 140(4):715-21. PubMed ID: 10233328
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic analysis in a case of hydroa vacciniforme-like eruptions associated with chronic active Epstein-Barr virus disease of γδ T cells.
Tanaka C; Hasegawa M; Fujimoto M; Iwatsuki K; Yamamoto T; Yamada K; Kawa K; Saikawa Y; Toga A; Mase S; Wada T; Takehara K; Yachie A
Br J Dermatol; 2012 Jan; 166(1):216-8. PubMed ID: 21729029
[No Abstract] [Full Text] [Related]
29. Hydroa vacciniforme-like lymphoproliferative disorder in Korea.
Han B; Hur K; Ohn J; Kim TM; Jeon YK; Kim YC; Mun JH
Sci Rep; 2020 Nov; 10(1):19294. PubMed ID: 33168864
[TBL] [Abstract][Full Text] [Related]
30. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
31. Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy.
El-Mallawany NK; Geller L; Bollard CM; Wistinghausen B; Mussai F; Wayne AS; Alobeid B; Cairo MS
Bone Marrow Transplant; 2011 May; 46(5):759-61. PubMed ID: 20661233
[No Abstract] [Full Text] [Related]
32. EBV-associated hydroa vacciniforme-like T-cell lymphoma.
Roy SF; Ghazawi FM; Powell J; Kokta V; Bélisle A
Br J Haematol; 2019 Sep; 186(6):802. PubMed ID: 31218678
[No Abstract] [Full Text] [Related]
33. Clinicopathologic Features of Hydroa Vacciniforme-Like Lymphoma: A Series of 9 Patients.
Magaña M; Massone C; Magaña P; Cerroni L
Am J Dermatopathol; 2016 Jan; 38(1):20-5. PubMed ID: 26368647
[TBL] [Abstract][Full Text] [Related]
34. Hydroa vacciniforme-like lymphoma: Clinicopathologic description, treatment, and outcome.
Xue R; Elbendary A; Liu H; Chen Y; Cleaver N; Elston DM
J Am Acad Dermatol; 2021 Sep; 85(3):752-755. PubMed ID: 31759090
[No Abstract] [Full Text] [Related]
35. Epstein-Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions.
Cho KH; Kim CW; Heo DS; Lee DS; Choi WW; Rim JH; Han WS
Clin Exp Dermatol; 2001 May; 26(3):242-7. PubMed ID: 11422165
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus-associated hydroa vacciniforme-like lymphoproliferative syndrome: excellent response to antiviral therapy.
İmren IG; Demirkan N; Çomut E; Duygulu Ş
Int J Dermatol; 2020 Dec; 59(12):e452-e454. PubMed ID: 32808321
[No Abstract] [Full Text] [Related]
37. Primary cutaneous T-cell lymphoma with an angiocentric growth pattern: association with Epstein-Barr virus.
Misago N; Ohshima K; Aiura S; Kikuchi M; Kohda H
Br J Dermatol; 1996 Oct; 135(4):638-43. PubMed ID: 8915164
[TBL] [Abstract][Full Text] [Related]
38. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.
Park S; Lee DY; Kim WS; Ko YH
Am J Dermatopathol; 2010 Dec; 32(8):832-6. PubMed ID: 20595887
[TBL] [Abstract][Full Text] [Related]
39. Hydroa vacciniforme with mucosal involvement and recalcitrant periodontitis and multiple virus re-activators after sun-exposure.
Nishizawa A; Satoh T; Takayama K; Yokozeki H
Acta Derm Venereol; 2010 Sep; 90(5):498-501. PubMed ID: 20814626
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus reactivation is induced, but abortive, in cutaneous lesions of systemic hydroa vacciniforme and hypersensitivity to mosquito bites.
Yamamoto T; Hirai Y; Miyake T; Hamada T; Yamasaki O; Morizane S; Fujimoto W; Iwatsuki K
J Dermatol Sci; 2016 Jun; 82(3):153-9. PubMed ID: 27039668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
